The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028.
The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However, strict government guidelines and lack of knowledge about detailed examination hinder the market growth.
Humans coexist with the diverse microbial species inhabiting within and on the surface of their bodies. Recent studies have highlighted that these microbial communities are essentially serving as another organ of the body as they play crucial roles in human physiology and disease progression. Several basic and translational research efforts have been initiated to focus on deciphering the microbiome function and its benefits to the human health. Many human medical conditions, such as inflammatory bowel diseases and obesity, have been closely associated with the composition of the gut microbial community; furthermore, conditions such as asthma and diabetes are thought to be influenced this microbial community. Many efforts are being taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements, and foods that contain live microbes have been studied thoroughly to assess their effects on human health. Also, several companies are designing and developing various microbiome therapies. Rebiotix Inc. has developed Microbiota Restoration Therapy (MRT) drug platform for delivering healthy, live, human-derived microbes into a sick patient’s intestinal tract to treat disease. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.
Based on product, the human microbiome market is further segmented into foods, medical foods, probiotics, prebiotics, drugs, diagnostic devices, and supplements. The market, by disease, is segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders, and other diseases. In 2021, the obesity segment is likely to hold the largest share of the market, whereas the market for the diabetes segment is expected to grow at the fastest CAGR during the forecast period. The surging prevalence of diabetes and growing research for treatment of diabetes are driving the growth of the human microbiome market.
The World Health Organization (WHO), National Health Service (NHS), Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services, American Academy of Dermatology, and company websites are among the major primary and secondary sources referred to while preparing the report on the human microbiome market.
The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However, strict government guidelines and lack of knowledge about detailed examination hinder the market growth.
Humans coexist with the diverse microbial species inhabiting within and on the surface of their bodies. Recent studies have highlighted that these microbial communities are essentially serving as another organ of the body as they play crucial roles in human physiology and disease progression. Several basic and translational research efforts have been initiated to focus on deciphering the microbiome function and its benefits to the human health. Many human medical conditions, such as inflammatory bowel diseases and obesity, have been closely associated with the composition of the gut microbial community; furthermore, conditions such as asthma and diabetes are thought to be influenced this microbial community. Many efforts are being taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements, and foods that contain live microbes have been studied thoroughly to assess their effects on human health. Also, several companies are designing and developing various microbiome therapies. Rebiotix Inc. has developed Microbiota Restoration Therapy (MRT) drug platform for delivering healthy, live, human-derived microbes into a sick patient’s intestinal tract to treat disease. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.
Based on product, the human microbiome market is further segmented into foods, medical foods, probiotics, prebiotics, drugs, diagnostic devices, and supplements. The market, by disease, is segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders, and other diseases. In 2021, the obesity segment is likely to hold the largest share of the market, whereas the market for the diabetes segment is expected to grow at the fastest CAGR during the forecast period. The surging prevalence of diabetes and growing research for treatment of diabetes are driving the growth of the human microbiome market.
The World Health Organization (WHO), National Health Service (NHS), Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services, American Academy of Dermatology, and company websites are among the major primary and secondary sources referred to while preparing the report on the human microbiome market.
Reasons to buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Human Microbiome Market - By Product
1.3.2 Global Human Microbiome Market - By Disease
1.3.3 Global Human Microbiome Market - By Application
1.3.4 Global Human Microbiome Market - By Geography
2. Global Human Microbiome Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Human Microbiome Market - Market Landscape
4.1 Overview
4.1.1 North America - PEST Analysis
4.1.2 Europe- PEST Analysis
4.1.3 Asia Pacific- PEST Analysis
4.1.4 Middle East And Africa- PEST Analysis
4.1.5 South and Central America - PEST Analysis
4.2 Expert Opinions
5. Human Microbiome Market- Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Incidence of Lifestyle Diseases
5.1.2 Increasing Focus On Human Microbiome Therapies
5.1.3 Growing Technological Advancements in Metagenomics and Next-generation Sequencing
5.2 Key Market Restraints
5.2.1 Strict Government Guidelines
5.2.2 Lack of Knowledge and Detailed Examination
5.3 Key Market Opportunities
5.3.1 New Drug Requirements for Faecal Microbiota
5.3.2 Emerging Nations
5.4 Future Trend
5.4.1 The Human Microbiome - A New Frontier in Drug Discovery
5.5 Impact analysis
6. Human Microbiome Market - Global Analysis
6.1 Global Human Microbiome Market Revenue Forecast and Analysis
6.2 Global Human Microbiome Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Human Microbiome Market Analysis - By Product
7.1 Overview
7.2 Human Microbiome Market Revenue Share, by Product (2021 and 2028)
7.3 Foods
7.3.1 Overview
7.3.2 Foods: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Medical Food
7.4.1 Overview
7.4.2 Medical Food: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Probiotics
7.5.1 Overview
7.5.2 Probiotics: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Prebiotics
7.6.1 Overview
7.6.2 Prebiotics: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Drugs
7.7.1 Overview
7.7.2 Drugs: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Diagnostic Devices
7.8.1 Overview
7.8.2 Diagnostic Devices: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
7.9 Supplements
7.9.1 Overview
7.9.2 Supplements: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
8. Human Microbiome Market Analysis - By Disease
8.1 Overview
8.2 Human Microbiome Market Revenue Share, by Disease (2021 and 2028)
8.3 Diabetes
8.3.1 Overview
8.3.2 Diabetes: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Cancer
8.4.1 Overview
8.4.2 Cancer: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Autoimmune Disorders
8.5.1 Overview
8.5.2 Autoimmune Disorders: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Obesity
8.6.1 Overview
8.6.2 Obesity: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Mental Disorders
8.7.1 Overview
8.7.2 Mental Disorders: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
9. Human Microbiome Market Analysis - By Application
9.1 Overview
9.2 Human Microbiome Market Revenue Share, by Application (2021 and 2028)
9.3 Therapeutics
9.3.1 Overview
9.3.2 Therapeutics: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostics
9.4.1 Overview
9.4.2 Diagnostics: Human Microbiome Market - Revenue and Forecast to 2028 (US$ Million)
10. Global Human Microbiome Market - Geographic Analysis
10.1 North America: Human Microbiome Market
10.1.1 Overview
10.1.2 North America: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America Human Microbiome Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.4 North America Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
10.1.5 North America Human Microbiome Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.6 North America: Human Microbiome Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US Human Microbiome Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US: Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US: Human Microbiome Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada Human Microbiome Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada Human Microbiome Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico Human Microbiome Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico Human Microbiome Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.2 Europe: Human Microbiome Market Revenue and Forecasts to 2028
10.2.1 Overview
10.2.2 Europe: Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.3 Europe Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.4 Europe Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
10.2.5 Europe Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.2.6 Europe Human Microbiome Market Revenue and Forecasts to 2028, By Country (%)
10.2.6.1 Germany Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.1.1 Germany Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.1.2 Germany Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.6.1.3 Germany Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
10.2.6.1.4 Germany Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.2.6.2 UK Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.2.1 UK Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.2.2 UK Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.6.2.3 UK Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
10.2.6.2.4 UK Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.2.6.3 France Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.3.1 France Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.3.2 France Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.6.3.3 France Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
10.2.6.3.4 France Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.2.6.4 Italy Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.4.1 Italy Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.4.2 Italy Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.6.4.3 Italy Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
10.2.6.4.4 Italy Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.2.6.5 Spain Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.5.1 Spain Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.5.2 Spain Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.6.5.3 Spain Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
10.2.6.5.4 Spain Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.2.6.6 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.6.1 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.6.2 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.6.6.3 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
10.2.6.6.4 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3 Asia Pacific: Human Microbiome Market
10.3.1 Overview
10.3.2 Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Human Microbiome Market, By Product, 2019-2028 (USD Million)
10.3.4 Asia Pacific: Human Microbiome Market, by Disease, 2019-2028 (USD Million)
10.3.5 Asia Pacific: Human Microbiome Market, by Application, 2019-2028 (USD Million)
10.3.6 Asia Pacific: Human Microbiome Market, by Country, 2021 & 2028 (%)
10.3.7 China: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.7.1 China: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.7.2 China: Human Microbiome Market, By Product, 2019-2028 (USD Million)
10.3.7.3 China: Human Microbiome Market, by Disease, 2019-2028 (USD Million)
10.3.7.4 China: Human Microbiome Market, by Application, 2019-2028 (USD Million)
10.3.8 Japan: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.8.1 Japan: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.8.2 Japan: Human Microbiome Market, By Product, 2019-2028 (USD Million)
10.3.8.3 Japan: Human Microbiome Market, by Disease, 2019-2028 (USD Million)
10.3.8.4 Japan: Human Microbiome Market, by Application, 2019-2028 (USD Million)
10.3.9 India: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.9.1 India: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.9.2 India: Human Microbiome Market, By Product, 2019-2028 (USD Million)
10.3.9.3 India: Human Microbiome Market, by Disease, 2019-2028 (USD Million)
10.3.9.4 India: Human Microbiome Market, by Application, 2019-2028 (USD Million)
10.3.10 Australia: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.10.1 Australia: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.10.2 Australia: Human Microbiome Market, By Product, 2019-2028 (USD Million)
10.3.10.3 Australia: Human Microbiome Market, by Disease, 2019-2028 (USD Million)
10.3.10.4 Australia: Human Microbiome Market, by Application, 2019-2028 (USD Million)
10.3.11 South Korea: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.11.1 South Korea: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.11.2 South Korea: Human Microbiome Market, By Product, 2019-2028 (USD Million)
10.3.11.3 South Korea: Human Microbiome Market, by Disease, 2019-2028 (USD Million)
10.3.11.4 South Korea: Human Microbiome Market, by Application, 2019-2028 (USD Million)
10.3.12 Rest of Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.12.1 Rest of Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)
10.3.12.2 Rest of Asia Pacific: Human Microbiome Market, By Product, 2019-2028 (USD Million)
10.3.12.3 Rest of Asia Pacific: Human Microbiome Market, by Disease, 2019-2028 (USD Million)
10.3.12.4 Rest of Asia Pacific: Human Microbiome Market, by Application, 2019-2028 (USD Million)
10.4 Middle East and Africa: Human Microbiome Market
10.4.1 Overview
10.4.2 Middle East & Africa: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East and Africa Human Microbiome Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.4.4 Middle East and Africa Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
10.4.5 Middle East and Africa Human Microbiome Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.4.6 Middle East and Africa: Human Microbiome Market, by Country, 2021 & 2028 (%)
10.4.6.1 Saudi Arabia: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Saudi Arabia: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.2 Saudi Arabia Human Microbiome Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3 Saudi Arabia Human Microbiome Market, by Disease- Revenue and Forecast to 2028 (USD Million)
10.4.6.1.4 Saudi Arabia Human Microbiome Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.4.6.2 UAE: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 UAE: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.2 UAE Human Microbiome Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3 UAE Human Microbiome Market, by Disease- Revenue and Forecast to 2028 (USD Million)
10.4.6.2.4 UAE Human Microbiome Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.4.6.3 South Africa: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 South Africa: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.2 South Africa Human Microbiome Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3 South Africa Human Microbiome Market, by Disease- Revenue and Forecast to 2028 (USD Million)
10.4.6.3.4 South Africa Human Microbiome Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.4.6.4 Rest of Middle East and Africa: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Rest of Middle East and Africa: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.2 Rest of Middle East and Africa Human Microbiome Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.4.6.4.3 Rest of Middle East and Africa Human Microbiome Market, by Disease- Revenue and Forecast to 2028 (USD Million)
10.4.6.4.4 Rest of Middle East and Africa Human Microbiome Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5 South and Central America: Human Microbiome Market
10.5.1 Overview
10.5.2 South and Central America: Human Microbiome Market- Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America Human Microbiome Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.5.4 South and Central America Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
10.5.5 South and Central America Human Microbiome Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.6 South and Central America: Human Microbiome Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Human Microbiome Market- Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Brazil: Human Microbiome Market- Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2 Brazil Human Microbiome Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.5.6.1.3 Brazil Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
10.5.6.1.4 Brazil Human Microbiome Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.6.2 Argentina: Human Microbiome Market- Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 Argentina: Human Microbiome Market- Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2 Argentina Human Microbiome Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.5.6.2.3 Argentina Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
10.5.6.2.4 Argentina Human Microbiome Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.6.3 Rest of South and Central America: Human Microbiome Market- Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Rest of South and Central America: Human Microbiome Market- Revenue and Forecast to 2028 (USD Million)
10.5.6.3.2 Rest of South and Central America Human Microbiome Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.5.6.3.3 Rest of South and Central America Human Microbiome Market, by Disease- Revenue and Forecast to 2028 (USD Million)
10.5.6.3.4 Rest of South and Central America Human Microbiome Market, by Application- Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Human Microbiome Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MaaT Pharma
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ELIGO BIOSCIENCE
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 AOBiome
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Kaleido Biosciences, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Seres Therapeutics
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck & Co., Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Yakult Honsha Co., Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Rebiotix, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 DuPont de Nemours, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Synthetic Biologics, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Publisher
14.2 Glossary of TermsList of Tables
Table 1. North America Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
Table 3. North America Human Microbiome Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 4. US Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 5. US Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)
Table 6. US Human Microbiome Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Human Microbiome Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Human Microbiome Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Europe and Middle East and Africa Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn).
Table 14. Europe and Middle East and Africa Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn).
Table 15. Europe and Middle East and Africa Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn).
Table 16. Germany Human Microbiome Market Revenue and Forecasts to 2028, By Product US$ Mn)
Table 17. Germany Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn).
Table 18. Germany Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn).
Table 19. UK Human Microbiome Market Revenue and Forecasts to 2028, By Product US$ Mn)
Table 20. UK Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn).
Table 21. UK Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn).
Table 22. France Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 23. France Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
Table 24. France Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 25. Italy Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 26. Italy Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
Table 27. Italy Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 28. Spain Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 29. Spain Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
Table 30. Spain Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 31. Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 32. Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)
Table 33. Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 34. Asia Pacific: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 35. Asia Pacific Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 36. Asia Pacific Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 37. China: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 38. China: Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 39. China: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 40. Japan: Human Microbiome Market, By Product– Revenue and Forecast to 2028 (USD Million)
Table 41. Japan: Human Microbiome Market, by Disease– Revenue and Forecast to 2028 (USD Million)
Table 42. Japan: Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 43. India: Human Microbiome Market, By Product– Revenue and Forecast to 2028 (USD Million)
Table 44. India: Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 45. India: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 46. Australia: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 47. Australia: Human Microbiome Market, by Disease– Revenue and Forecast to 2028 (USD Million)
Table 48. Australia: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 49. South Korea: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 50. South Korea: Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 51. South Korea: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Asia Pacific: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia Pacific: Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia Pacific: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 55. Middle East and Africa Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 56. Middle East and Africa Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 57. Middle East and Africa Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 58. Saudi Arabia Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 59. Saudi Arabia Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 60. Saudi Arabia Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 61. UAE Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 62. UAE Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 63. UAE Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 64. South Africa Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 65. South Africa Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 66. South Africa Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 67. Rest of Middle East and Africa Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 68. Rest of Middle East and Africa Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Middle East and Africa Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 70. South and Central America Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 73. Brazil Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 74. Brazil Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 76. Argentina Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 77. Argentina Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of South and Central America Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South and Central America Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 82. Organic Developments Done By Companies
Table 83. Inorganic Developments Done by Companies
Table 84. Glossary of Terms, Human Microbiome MarketList of Figures
Figure 1. Human Microbiome Market Segmentation
Figure 2. Human Microbiome Market Segmentation, By Region
Figure 3. Global Human Microbiome Market Overview
Figure 4. Probiotics Segment Held the Largest Share of the Product Segment in Human Microbiome Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Human Microbiome Market, by Geography (US$ Million)
Figure 7. Global Human Microbiome Market – Leading Country Markets (US$ Million)
Figure 8. Global Human Microbiome Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Human Microbiome Market Impact Analysis of Driver and Restraints
Figure 15. Global Human Microbiome Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Human Microbiome Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Human Microbiome Market
Figure 18. Human Microbiome Market Revenue Share, by Product (2021 and 2028)
Figure 19. Foods: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Medical Food: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Probiotics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Prebiotics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Drugs: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diagnostic Devices: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Supplements: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Human Microbiome Market Revenue Share, by Disease (2021 and 2028)
Figure 27. Diabetes: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Cancer: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Autoimmune Disorders: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Obesity: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Mental Disorders: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Others: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Human Microbiome Market Revenue Share, by Application (2021 and 2028)
Figure 34. Therapeutics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Diagnostics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America: Human Microbiome Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. North America Human Microbiome Market Revenue and Forecast to 2028 (USD Million)
Figure 38. North America: Human Microbiome Market, by Country, 2021 & 2028 (%)
Figure 39. US: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Canada: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Mexico: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Europe: Human Microbiome Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 43. Europe Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 44. Europe Human Microbiome Market Revenue and Forecasts to 2028, By Country (%)
Figure 45. Germany Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 46. UK Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47. France Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 48. Italy Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 49. Spain Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 50. Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 51. Asia Pacific: Human Microbiome Market, by Key Country – Revenue (2021) (USD Million)
Figure 52. Asia Pacific Human Microbiome Market Revenue and Forecast to 2028 (USD Million)
Figure 53. Asia Pacific: Human Microbiome Market, by Country, 2021 & 2028 (%)
Figure 54. China: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Japan: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. India: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. Australia: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. South Korea: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. Rest of Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Middle East and Africa: Human Microbiome Market, by Key Country – Revenue (2021) (USD Million)
Figure 61. Middle East & Africa Human Microbiome Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Middle East and Africa: Human Microbiome Market, by Country, 2021 & 2028 (%)
Figure 63. Saudi Arabia: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)
Figure 64. UAE: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)
Figure 65. South Africa: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)
Figure 66. Rest of Middle East and Africa: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)
Figure 67. South and Central America: Human Microbiome Market, by Key Country – Revenue (2021) (USD Million)
Figure 68. South and Central America Human Microbiome Market Revenue and Forecast to 2028 (USD Million)
Figure 69. South and Central America: Human Microbiome Market, by Country, 2021 & 2028 (%)
Figure 70. Brazil: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)
Figure 71. Argentina: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)
Figure 72. Rest of South and Central America: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)
Figure 73. Impact of COVID-19 Pandemic In North American Country Markets
Figure 74. Impact of COVID-19 Pandemic In European Country Markets
Figure 75. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 76. Impact Of COVID-19 Pandemic In Rest of the World Market
Figure 77. Impact Of COVID-19 Pandemic in Rest of the World Market
Figure 78. Growth Strategies Done by the Companies in the Market, (%)
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Synthetic Biologics Inc.
- DuPont
- MaaT Pharma
- Eligo Bioscience
- Merck & Co. Inc
- AOBiome LLC
- Kaleido
- Seres Therapeutics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 188 |
| Published | August 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 718.95 Million |
| Forecasted Market Value ( USD | $ 2921.68 Million |
| Compound Annual Growth Rate | 22.2% |
| Regions Covered | Global |
![Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030] - Product Image](http://www.researchandmarkets.com/product_images/12371/12371581_60px_jpg/human_microbiome_market_[20242030].jpg)
